Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature.It is often difficult to treat, requires a ...

Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced the appointment of Beth Marsh as Chief Commercial Officer, ...

Researchers have uncovered the 3D structure of RBP3, a key protein in vision, revealing how it transports retinoids and fatty ...

Eyestem Research Pvt Ltd announced positive results from its phase 1/2 trial ( NCT06394232) evaluating its investigational ...

Typically, myopic CNV is located between the neurosensory retina and the retinal pigment epithelial layer. [13] The sensory retinal elevation associated with this CNV seems to be extremely small ...

Proteins are fundamental biomolecules that perform a broad range of vital functions within the human body. They serve as an essential structural and functional component of cells, tissues and organs ...

This involves transplanting newly differentiated retinal pigment epithelial cells, derived from human embryonic stem cells, into the back of the eye. It has helped to restore vision in animals 3 ...

Eyecyte-RPE is a cryopreserved, allogeneic retinal pigment epithelium (RPE) cell suspension designed to replace damaged retinal cells and restore vision. The trial, after receiving approval from the ...

Kleinman from East Tennessee State University, reveals that aging causes inflammation, oxidative stress, and gene disruption in the retinal pigment epithelium (RPE), a vital layer of cells in the eye.

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Lineage's Chief Executive ...